The recent decision by the Federal Circuit has breathed new life into a patent suit involving a blood pump, filed by a division of the Swedish medical device producer Getinge AB. This legal development overturns an earlier ruling by a federal judge in Massachusetts, whose interpretation of the patent claims had previously led all parties to agree that there was no infringement. As a result, the case against a Johnson & Johnson MedTech subsidiary has been revived, underscoring the nuances and complexities that often accompany patent litigation.
This case highlights the critical role of claim construction in patent suits, a process that can determine the fate of a case based on how patent claims are interpreted by the courts. Errors or disputes in this stage can significantly alter the trajectory of litigation, as seen in this instance. For more detailed information regarding this development, visit the report on Law360.